Company intelligence / Profile preview

BioSpectra

Bangor, Pennsylvania, United Statesbiospectra.us ↗

Ownership: Private
Employees: ~201
Development stage: Commercial

Overview

BioSpectra manufactures cGMP fine chemicals—including biological buffers, amino acids, carbohydrates/dextrans, excipients and APIs—used globally by biopharma companies and contract manufacturers. The company operates multiple US-based cGMP facilities with rigorous quality systems supporting FDA/ICH compliance. It does not have a clinical pipeline as it does not develop finished therapeutics.

Modalities: Small moleculeBiologicExcipientActive pharmaceutical ingredient (API)Carbohydrate polymerAmino acid derivative
Industry: Chemicals & Materials

Beyond the preview

Go deeper on BioSpectra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSpectra.

Explore the full profile